Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - MDCX


VANCOUVER, BC, April 25, 2024 /CNW/ - Trading resumes in:

Company: Medicus Pharma Ltd.

TSX-Venture Symbol: MDCX

All Issues: Yes

Resumption (ET): 08:00 AM 04/26/2024

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 07:10
FiscalNote Reports First Quarter 2024 Financial Results
FiscalNote Holdings, Inc. ("FiscalNote" or the "Company"), a leading information services company using AI-driven enterprise SaaS technology to provide global political, legislative and regulatory policy and market intelligence, today reported...

at 07:10
Piedmont Lithium Reports Q1 2024 Results
Piedmont Lithium Inc. ("Piedmont," the "Company," "we," "our," or "us") , a leading North American supplier of lithium products critical to the U.S. electric vehicle supply chain, today reported its first quarter 2024 financial results. North...

at 07:10
Shift4 Announces First Quarter 2024 Results
Shift4 , the leader in integrated payments and commerce technology, has posted its first quarter 2024 financial results as part of its Q1 2024 Shareholder Letter, which can be viewed here or by navigating to the Financials section of its Investor...

at 07:10
Charles River Laboratories Announces First-Quarter 2024 Results
Charles River Laboratories International, Inc. today reported its results for the first quarter of 2024. For the quarter, revenue was $1.01 billion, a decrease of 1.7% from $1.03 billion in the first quarter of 2023. The impact of foreign currency...

at 07:10
Nexstar Media Group Reports Record First Quarter Net Revenue of $1.28 Billion
Nexstar Media Group, Inc. ("Nexstar" or the "Company") today reported financial results for the first quarter ended March 31, 2024. Please visit Nexstar's website to view the full press release. STATEMENT FROM PERRY A. SOOK, FOUNDER, CHAIRMAN AND...

at 07:10
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
Apyx Medical Corporation ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results for its first quarter ended March 31, 2024; and...

More news about Business...


News published on and distributed by: